Information for Patients

Positive COVID-19 test? Call a health care provider and ask about monoclonal antibody treatment.

Monoclonal antibody treatments are available for people with COVID-19 who meet criteria for risk of developing severe illness.

If your provider needs more information about mAb, send them to Information for Health Care Providers.

If you don't have a primary care provider, you can...

Visit UCHealth Virtual Urgent Care (may be subject to a $49 fee) to see if you qualify and get connected to mAb treatment. You can also call 303-529-9313 if you have trouble registering online.

Or Denver Health Federico F. Peña Southwest Urgent Care Clinic on Federal Boulevard can diagnose COVID-19 and administer mAb treatment during urgent care visits. Additionally, mAb infusions can be scheduled. Visit may be subject to a copay request. Call 303-602-0999 for more information.

For more information:

Visit the Colorado Department of Public Health & Environment (CDPHE):  COVID-19 treatments to find out more about resources in Colorado for receiving monoclonal antibody (mAb) treatments.

Find mAb treatment locations: Colorado Infusion Center Map: Generated by CDPHE, this map can be used to find the nearestinfusion center where you can receive mAb treatment.

    Important Information:

    The following medical conditions or other factors may place adults and pediatric patients (age 12-17 years and weighing at least 40kg) at higher risk for progression to severe COVID-19:


    Ages 65+


    Obesity or being overweight

    • Adults ages 18-64 with BMI >25
    • Children age 12-17 who have a BMI >85th percentile for their age and gender based on CDC growth charts.

    Other medical conditions or factors (for example, race or ethnicity) may also place individual patients at high risk for progression to severe COVID-19. For additional information, see the CDC website.


    People ages 12-64 with one or more of the following conditions:

    • Pregnancy.
    • Chronic kidney disease.
    • Diabetes.
    • Immunosuppressive disease or immunosuppressive treatment.
    • Cardiovascular diseases (for example, chronic obstructive pulmonary disease [moderate to severe], interstitial lung disease, cystic fibrosis, and pulmonary hypertension).
    • Sickle cell disease.
    • Neurodevelopment disorders (for example, cerebral palsy) or other medically complex conditions (for example, genetic or metabolic syndromes and severe congenital abnormalities).
    • Having a medically-related technological dependence (for example, tracheostomy, gastrostomy, or positive pressure ventilation [not related to COVID-19]).


    **The FDA updated eligibility criteria for monoclonal antibody treatments on May 14, 2021.**

    Are You Eligible?


    mAb Eligibility infographic V5


    Follow Us on Social Media









    This project is funded by a grant from the National Institutes of Health (NIH) and National Center for Advancing Translational Sciences (NCATS) (award number UL1-TR002535-03S3).